Fate Therapeutics Inc. | Balance Sheet
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
54,036.00
49,101.00
64,809.00
92,112.00
100,949.00
201,007
Other Current Assets
615.00
771.00
843.00
1,211.00
1,647.00
3,689
Total Current Assets
54,651.00
49,872.00
65,652.00
93,323.00
102,596.00
205,196
Net Property, Plant & Equipment
810.00
1,200.00
2,160.00
1,579.00
2,550.00
5,125
Total Investments and Advances
122.00
122.00
122.00
122.00
122.00
227
Other Assets
-
10.00
24.00
24.00
24.00
526
Total Assets
55,583.00
51,204.00
67,958.00
95,048.00
105,292.00
213,032
ST Debt & Current Portion LT Debt
1,732.00
1,546.00
7,550.00
8,187.00
-
Accounts Payable
682.00
-
-
934.00
1,678.00
Other Current Liabilities
2,186.00
3,035.00
5,891.00
6,066.00
9,371.00
Total Current Liabilities
4,600.00
4,581.00
13,441.00
15,187.00
11,049.00
Long-Term Debt
-
18,083.00
10,688.00
2,501.00
14,808.00
Other Liabilities
135.00
200.00
5,791.00
4,206.00
2,246.00
Total Liabilities
4,735.00
22,864.00
29,920.00
21,894.00
28,103.00
Common Equity (Total)
50,848.00
28,340.00
38,038.00
73,151.00
77,186.00
Total Shareholders' Equity
50,848.00
28,340.00
38,038.00
73,154.00
77,189.00
Total Equity
50,848.00
28,340.00
38,038.00
73,154.00
77,189.00
Liabilities & Shareholders' Equity
55,583.00
51,204.00
67,958.00
95,048.00
105,292.00
Preferred Stock (Carrying Value)
-
-
-
3.00
3.00
About Fate Therapeutics
View Profile
